Medications

GLP-1 therapies, dosed for you.

Both medications are compounded and dispensed by our partner pharmacies, Strive and Stryker. Your dose is selected by your provider based on your health history, goals, and how you respond to treatment.

Weekly injection

Compounded Semaglutide

Semaglutide (GLP-1)

Once-weekly GLP-1 therapy that slows gastric emptying, curbs cravings, and supports sustained appetite regulation.

Weekly self-administered injection
Titrated slowly to minimize side effects
Sourced from Strive & Stryker Pharmacy

Start intake for Semaglutide

Available doses

Your provider will select the right starting point

Starter — 0.25 mg / week
Recommended starting dose
Standard — 0.5 mg / week
Advanced — 1.0 mg / week
Maintenance — 1.7 mg / week

Weekly injection

Compounded Tirzepatide

Tirzepatide (GLP-1 / GIP)

A dual GIP/GLP-1 agonist offering enhanced appetite control and metabolic response for patients ready for the next step.

Weekly self-administered injection
Dual-agonist mechanism (GIP + GLP-1)
Sourced from Strive & Stryker Pharmacy

Start intake for Tirzepatide

Available doses

Your provider will select the right starting point

Starter — 2.5 mg / week
Recommended starting dose
Standard — 5 mg / week
Advanced — 7.5 mg / week
Maintenance — 10 mg / week

Please note: Compounded GLP-1 medications are prepared by state-licensed 503A pharmacies. They are not FDA-approved and are prescribed only when clinically appropriate following provider review. A one-time $49 intake fee is billed at the start of care. Monthly medication pricing will be discussed with your provider after intake review.